CAS 75067-66-2: 4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl decanoate

Bromperidol decanoate for system suitability CRS

BROMPERIDOL DECANOATE CRS

Compounds containing an unfused pyridine ring in the structure, nesoi

Bromperidol decanoate is a long-acting injectable form of the antipsychotic drug Bromperidol. It is used to treat schizophrenia and other psychotic disorders, as well as for the short-term treatment of insomnia. Paliperidone is a selective serotonin antagonist that blocks postsynaptic serotonin receptors. It is structurally related to risperidone, but it has fewer extrapyramidal side effects. Bromperidol decreases the symptoms associated with chronic schizophrenia and also relieves agitation in psychiatric patients. This drug acts by binding to dopamine receptors in the brain and blocking dopamine activity, which reduces psychotic symptoms and improves concentration. The decanoate ester allows for a slow release of bromperidol into the bloodstream over time, while paliperidone is rapidly broken down by enzymes in the liver. Bromperidol has been shown to be safe for use in humans at doses up to 20 mg/kg/day; however, adverse reactions are

Applications Bromoperidol Decanoate is used in the treatment of neurological diseases and patients suffering from neurological disorders such as schizophrenia. References Gopal, S. et al.: Neuropsych. Dis. Treat., 7, 93 (2011);